Previous 10 | Next 10 |
Summary Cathie Wood and her ARK Investment Management have just turned their backs on their worst year of performance since the inception of the investing firm. The market continued to systematically dissect any leftover enthusiasm in the growth and technology space, significantly hurti...
GUILFORD, Conn., Feb. 21, 2023 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking medical device company that created the Swoop ® system, the world's first FDA-cleared portable MRI system, today announced CE Marking for the product. While the company will maintain its...
GUILFORD, Conn., Feb. 13, 2023 (GLOBE NEWSWIRE) -- Hyperfine, Inc., the groundbreaking medical device company that created the Swoop ® system, the world’s first FDA-cleared portable magnetic resonance imaging (MRI) device for imaging of the brain, today announced the U.S. Food and...
GUILFORD, Conn., Feb. 09, 2023 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking medical device company that created the Swoop ® system, the world's first FDA-cleared portable MRI system, today announced the presentation of new data regarding the use of the Swoop &...
Hyperfine ( NASDAQ: HYPR ) said Brett Hale had been appointed as the Chief Administrative Officer & Chief Financial Officer, effective FEb. 13. Alok Gupta, who currently serves as CFO , will step down on or about March 31. For further details see: Hyperfine appo...
GUILFORD, Conn., Feb. 08, 2023 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking medical device company that created Swoop®, the world's first FDA-cleared portable MRI system™, today announced that Brett Hale will join Hyperfine, Inc. on February 13, 2023 and will...
GUILFORD, Conn., Feb. 06, 2023 (GLOBE NEWSWIRE) -- Hyperfine, Inc., creator of the Swoop® Point-of-Care MRI System™ for imaging of the brain, today announced the acceptance of twelve abstracts related to the Swoop® system to be presented at the prestigious International Society f...
GUILFORD, Conn., Nov. 22, 2022 (GLOBE NEWSWIRE) -- Hyperfine (Nasdaq: HYPR), the groundbreaking medical device company that created Swoop®, the world's first FDA-cleared portable MRI system™, today announced that the company will be participating in the upcoming 5 th Annual&...
Hyperfine, Inc. (HYPR) Q3 2022 Earnings Conference Call November 10, 2022 4:30 PM ET Company Participants Marissa Bych – Investor Relations Maria Sainz – President and Chief Executive Officer Alok Gupta – Chief Financial Officer Scott Hue...
The following slide deck was published by Hyperfine, Inc. in conjunction with their 2022 Q3 earnings call. For further details see: Hyperfine, Inc. 2022 Q3 - Results - Earnings Call Presentation
News, Short Squeeze, Breakout and More Instantly...
The total number of Hyperfine AI-powered marketing authorizations places the company in a leading position on recently published FDA list. Hyperfine (Nasdaq: HYPR), the groundbreaking medical device company that has redefined brain imaging with the world’s first FDA-cleared porta...
The publication includes a subset of data from the ACTION PMR stroke study and provides early evidence that the Swoop ® system is a promising tool for enabling critical stroke treatment choices in urgent care settings. Hyperfine (Nasdaq: HYPR), the groundbreaking health technol...
Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable magnetic resonance (MR) brain imaging system—the Swoop® system—today announced that it will report financial results for the second ...